Open AccessEfficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1
Author(s) -
Okayama Yusuke,
Takakuwa Teruhito,
Otomaru Ippei,
Horiuchi Mirei,
Miura Akiko,
Araki Taku,
Fujitani Yotaro,
Yamamura Ryosuke
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4126
Subject(s) - medicine , imatinib , phenotype , philadelphia chromosome , oncology , leukemia , imatinib mesylate , chromosomal translocation , gene , myeloid leukemia , genetics , biology
Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.